As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Contraceptive Drugs Market: By Product: Topical Contraceptives, Oral Contraceptive Pills, Injectable Contraceptives; By Age Group: 15-24 years, 25-34 years, Others; By End-User; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Contraceptive Drugs Market Outlook

The global contraceptive drugs market attained a value of about USD 16.37 billion in 2021. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 6.96% to reach nearly USD 24.50 billion by 2027.

 

Increasing Availability of Free and Subsidised Contraceptive Drugs Driving the Market Growth

As governments are increasingly attempting to enhance the quality of life of their citizens, they are increasingly providing free and subsidised contraceptive drugs, thereby driving the growth of the market. Moreover, governments of low-and-middle-income companies are launching various favourable initiatives like advertisements to promote contraceptive drugs among their population.

 

Global Contraceptive Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

For instance, in July 2019, the Health Ministry of India released about three commercials to promote oral contraceptives. In addition, various governments are selling contraceptive pills at pharmacy stores without doctor’s prescriptions, which is significantly contributing to the growth of the market.

The initiation of various family planning programmes and media campaigns to increase awareness regarding the importance and benefits of contraceptive drugs is augmenting the market growth. The redistribution of contraceptive services among health workers and pharmacy staff, among others, is increasing the accessibility of the underserved population of injectables and oral contractions. Hence, the increasing availability of diverse contraceptive drugs in developing countries is aiding the market growth. The development of new contraceptive technologies to boost the functionality and efficiency of contraceptive drugs is providing further impetus to the growth of the market.

 

Contraceptive Drugs: Industry Definition and Segmentation

Contraceptive drugs, variously known as birth control drugs, are medicines that prevent unwanted pregnancies by releasing hormones like oestrogen and progesterone. They thicken mucus around the cervix to prevent ovulation. Contraceptive drugs are convenient to use and lower the risk of various health-related issues like breast cancer and polycystic ovary syndrome (PCOS), among others.

The major products of contraceptive drugs are:

  • Topical Contraceptives
  • Oral Contraceptive Pills
  • Injectable Contraceptives

The market can be broadly categorised on the basis of its age groups into:

  • 15-24 years
  • 25-34 years
  • 35-44 years
  • Above 44 years

Based on end-users, the market is divided into:

  • Homecare
  • Hospitals
  • Clinics

The EMR report looks into the regional markets of contraceptive drugs like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Development of Contraceptive Drugs with Minimal Side Effects to Augment the Market Growth

The development of innovative contraceptive drugs to minimise the side-effects like nausea and vomiting is propelling the market growth. With the increasing attempts to boost the benefits of contraceptive drugs, new modes for their administration to enhance patient experience is surging, which is aiding the market growth. Furthermore, the increasing research activities to develop advanced contraceptive drugs is expected to propel the market growth. The rising acceptance of innovative contraceptive drugs like once-a-month pills to prevent ovulation or implantation is significantly contributing to the growth of the industry.

The increasing focus to provide innovative solutions for shared reproductive burden among both males and females is anticipated to drive the growth of the market. This is also leading to the initiation of various clinical trials of contraceptive drugs that stop sperm production to prevent unplanned pregnancies. As conventional contraceptive drugs result in side effects like nausea, vomiting, and mood swings, among others, long-acting reversible contraceptives are being developed, which is anticipated to bolster the industry growth. Moreover, increasing research activities to develop oestrogen-free drugs to lower failure rates as compared to oestrogen-based contraception is predicted to propel the market growth.

 

Key Industry Players in the Global Contraceptive Drugs Market

The report presents a detailed analysis of the following key players in the global contraceptive drugs market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Allergan plc
  • Johnson & Johnson
  • Bayer AG
  • Piramal Healthcare
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Age Group, End-User, Region
Breakup by Product Topical Contraceptives, Topical Contraceptives, Injectable Contraceptives
Breakup by Age Group 15-24 years, 25-34 years, 35-44 years, Above 44 years
Breakup by End-User Homecare, Hospitals, Clinics
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Allergan plc, Johnson & Johnson, Bayer AG, Piramal Healthcare, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Contraceptive Drugs Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Contraceptive Drugs Historical Market (2017-2021) 
    8.3    Global Contraceptive Drugs Market Forecast (2022-2027)
    8.4    Global Contraceptive Drugs Market by Product
        8.4.1    Topical Contraceptives
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Oral Contraceptive Pills
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Injectable Contraceptives
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
    8.5    Global Contraceptive Drugs Market by Age Group
        8.5.1    15-24 years
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    25-34 years
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    35-44 years
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Above 44 years
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2017-2021)
            8.5.4.3    Forecast Trend (2022-2027)
    8.6    Global Contraceptive Drugs Market by End-User
        8.6.1    Homecare
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Hospitals
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Clinics
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
    8.7    Global Contraceptive Drugs Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Allergan plc
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Johnson & Johnson
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Bayer AG
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Piramal Healthcare
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Pfizer Inc.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Teva Pharmaceutical Industries Ltd.
            12.2.6.1    Company Overview
            12.2.6.2    Product Portfolio
            12.2.6.3    Demographic Reach and Achievements
            12.2.6.4    Certifications
        12.2.7    Novartis AG
            12.2.7.1    Company Overview
            12.2.7.2    Product Portfolio
            12.2.7.3    Demographic Reach and Achievements
            12.2.7.4    Certifications
        12.2.8    Others
13    Industry Events and Developments

 

List of Figures and Tables

1.    Global Contraceptive Drugs Market: Key Industry Highlights, 2017 and 2027
2.    Global Contraceptive Drugs Historical Market: Breakup by Product (USD Billion), 2017-2021
3.    Global Contraceptive Drugs Market Forecast: Breakup by Product (USD Billion), 2022-2027
4.    Global Contraceptive Drugs Historical Market: Breakup by Age Group (USD Billion), 2017-2021
5.    Global Contraceptive Drugs Market Forecast: Breakup by Age Group (USD Billion), 2022-2027
6.    Global Contraceptive Drugs Historical Market: Breakup by End-User (USD Billion), 2017-2021
7.    Global Contraceptive Drugs Market Forecast: Breakup by End-User (USD Billion), 2022-2027
8.    Global Contraceptive Drugs Historical Market: Breakup by Region (USD Billion), 2017-2021
9.    Global Contraceptive Drugs Market Forecast: Breakup by Region (USD Billion), 2022-2027
10.    North America Contraceptive Drugs Historical Market: Breakup by Country (USD Billion), 2017-2021
11.    North America Contraceptive Drugs Market Forecast: Breakup by Country (USD Billion), 2022-2027
12.    Europe Contraceptive Drugs Historical Market: Breakup by Country (USD Billion), 2017-2021
13.    Europe Contraceptive Drugs Market Forecast: Breakup by Country (USD Billion), 2022-2027
14.    Asia Pacific Contraceptive Drugs Historical Market: Breakup by Country (USD Billion), 2017-2021
15.    Asia Pacific Contraceptive Drugs Market Forecast: Breakup by Country (USD Billion), 2022-2027
16.    Latin America Contraceptive Drugs Historical Market: Breakup by Country (USD Billion), 2017-2021
17.    Latin America Contraceptive Drugs Market Forecast: Breakup by Country (USD Billion), 2022-2027
18.    Middle East and Africa Contraceptive Drugs Historical Market: Breakup by Country (USD Billion), 2017-2021
19.    Middle East and Africa Contraceptive Drugs Market Forecast: Breakup by Country (USD Billion), 2022-2027
20.    Global Contraceptive Drugs Market Structure

Key Questions Answered in the Report

In 2021, the global contraceptive drugs market attained a value of nearly USD 16.37 billion.

The market is projected to grow at a CAGR of 6.96% between 2022 and 2027.

The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach about USD 24.50 billion by 2027.

The market is being aided by the increasing availability of free and subsidised contraceptive drugs, the initiation of various family planning programmes and media campaigns, and the development of new contraceptive technologies.

The industry is expected to be augmented by the development of advanced contraceptive drugs, the rising acceptance of innovative contraceptive drugs, and the increasing clinical trials of contraceptive drugs for men.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major products of contraceptive drugs in the industry are topical contraceptives, oral contraceptive pills, and injectable contraceptives.

The significant age groups in the market are 15-24 years, 25-34 years, 35-44 years, and above 44 years.

The various end-users of contraceptive drugs are homecare, hospitals, and clinics.

The major players in the industry are Allergan plc, Johnson & Johnson, Bayer AG, Piramal Healthcare, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Novartis AG, among others.

Analyst Review

The global contraceptive drugs market attained a value of nearly USD 16.37 billion in 2021, driven by the increasing availability of free and subsidised contraceptive drugs. Aided by the rising acceptance of innovative contraceptive drugs, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 6.96%. The market is projected to reach about USD 24.50 billion by 2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its products, the contraceptive drugs industry can be segmented into topical contraceptives, oral contraceptive pills, and injectable contraceptives. On the basis of age groups, the industry is divided into 15-24 years, 25-34 years, 35-44 years, and above 44 years. By end-users, the market is categorised into homecare, hospitals, and clinics. The major regional markets for contraceptive drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Allergan plc, Johnson & Johnson, Bayer AG, Piramal Healthcare, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Novartis AG, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER